Intra-Cellular Therapies, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Report date

3/31/2025

Quarter

2025 Q1

Filed

9/15/2025

Shares

895,664

Value ($000)

118,156

Weight

0.0%

2014 Q1 - 2025 Q1 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	9/15/2025	118,156	0.0%	895,664	3/31/2025
2024 Q4	2/6/2025	75,723	0.0%	906,646	12/31/2024
2024 Q3	11/12/2024	66,212	0.0%	904,909	9/30/2024
2024 Q2	8/12/2024	63,084	0.0%	921,069	6/30/2024
2024 Q1	5/9/2024	69,605	0.0%	1,005,848	3/31/2024
2023 Q4	2/6/2024	71,177	0.0%	993,813	12/31/2023
2023 Q3	11/8/2023	50,783	0.0%	974,914	9/30/2023
2023 Q2	8/10/2023	45,305	0.0%	715,490	6/30/2023
2023 Q1	5/12/2023	37,872	0.0%	699,389	3/31/2023
2022 Q4	2/13/2023	36,875	0.0%	696,804	12/31/2022
2022 Q3	11/14/2022	31,662	0.0%	680,459	9/30/2022
2022 Q2	8/15/2022	35,719	0.0%	625,764	6/30/2022
2022 Q1	5/13/2022	37,188	0.0%	607,737	3/31/2022
2021 Q4	2/11/2022	27,138	0.0%	518,477	12/31/2021
2021 Q3	11/16/2021	18,995	0.0%	509,500	9/30/2021
2021 Q2	8/16/2021	20,044	0.0%	491,013	6/30/2021
2021 Q1	5/17/2021	16,122	0.0%	475,134	3/31/2021
2020 Q4	2/16/2021	14,564	0.0%	457,962	12/31/2020
2020 Q3	11/13/2020	11,377	0.0%	443,373	9/30/2020
2020 Q2	8/20/2020	9,380	0.0%	365,376	6/30/2020
2020 Q1	5/15/2020	5,215	0.0%	339,286	3/31/2020
2019 Q4	2/7/2020	9,577	0.0%	279,124	12/31/2019
2014 Q2	7/30/2014	737	0.0%	43,712	6/30/2014
2014 Q1	4/29/2014	346	0.0%	18,996	3/31/2014